» Articles » PMID: 15833765

Primary Type II Alveolar Epithelial Cells Present Microbial Antigens to Antigen-specific CD4+ T Cells

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Type II alveolar epithelial cells (AEC) can produce various antimicrobial and proinflammatory effector molecules. This, together with their abundance and strategic location, suggests a role in host defense against pulmonary pathogens. We report that murine type II AEC, like their human counterparts, express class II major histocompatibility complex (MHC). Using a murine model of pulmonary tuberculosis, we find that type II AEC become activated and have increased cell surface expression of class II MHC, CD54, and CD95 following infection. Type II AEC use the class II MHC pathway to process and present mycobacterial antigens to immune CD4+ T cells isolated from mice infected with Mycobacterium tuberculosis. Therefore, not only can type II AEC contribute to the pulmonary immunity by secreting chemokines that recruit inflammatory cells to the lung, but they can also serve as antigen-presenting cells. Although type II AEC are unlikely to prime naïve T cells, their ability to present antigens to T cells demonstrates that they can participate in the effector phase of the immune response. This represents a novel role for type II AEC in the immunological response to pulmonary pathogens.

Citing Articles

Cytotoxic CD4+ T Cells Are Induced during Infection with Chlamydia trachomatis.

Olivas J, Nogueira C, Helble J, Starnbach M J Immunol. 2024; 213(3):328-338.

PMID: 38905023 PMC: 11279525. DOI: 10.4049/jimmunol.2300131.


ERK1/2-CEBPB Axis-Regulated hBD1 Enhances Anti-Tuberculosis Capacity in Alveolar Type II Epithelial Cells.

Chen Y, Han Z, Zhang S, Liu H, Wang K, Liu J Int J Mol Sci. 2024; 25(4).

PMID: 38397085 PMC: 10889425. DOI: 10.3390/ijms25042408.


Cytotoxic CD4 T cells in chronic viral infections and cancer.

Malyshkina A, Bruggemann A, Paschen A, Dittmer U Front Immunol. 2023; 14:1271236.

PMID: 37965314 PMC: 10642198. DOI: 10.3389/fimmu.2023.1271236.


A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention.

Gopallawa I, Dehinwal R, Bhatia V, Gujar V, Chirmule N Front Immunol. 2023; 14:1119564.

PMID: 37063828 PMC: 10102582. DOI: 10.3389/fimmu.2023.1119564.


The underappreciated role of resident epithelial cell populations in metastatic progression: contributions of the lung alveolar epithelium.

Christenson J, Williams M, Richer J Am J Physiol Cell Physiol. 2022; 323(6):C1777-C1790.

PMID: 36252127 PMC: 9744653. DOI: 10.1152/ajpcell.00181.2022.